The Food and Drug Administration (FDA) has approved Tevimbra® (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the ...

The Food and Drug Administration (FDA) has approved Stoboclo® (denosumab-bmwo), a biosimilar to Prolia® (denosumab), and Osenvelt® (denosumab-bmwo), a ...

The Food and Drug Administration (FDA) has granted Priority Review to the Biologics License Application (BLA) for deramiocel (CAP-1002) for the treatment ...

The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel (repository corticotropin injection USP) in a prefilled syringe presentation. Cortrophin Gel is a purified ...

In honor of Women’s History Month, MPR has created a quiz to celebrate the groundbreaking contributions of women in medicine. Test your knowledge and see ...

After adjustment for confounding variables, no increased risk seen for GLP-1 receptor agonists versus DPP-4 inhibitors, SGLT-2 inhibitors ...

Significant reduction seen in median headache days per month in both intractable and nonintractable migraine groups ...

Based on preliminary data for 2024 to 2025, 13% of pediatric deaths had influenza-associated encephalopathy, encephalitis.

Newly appointed health secretary believes processing the comments under the Richardson Waiver puts too heavy a burden on the department ...

The Food and Drug Administration (FDA) has expanded the approval of Odactra® (house dust mite allergen tablet) to include the treatment of house dust mite ...

The Food and Drug Administration (FDA) has granted Fast Track designation to AVB-114 for the treatment of perianal fistulas in patients with Crohn ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for emapalumab-Izsg for use ...